INO Inovio Pharmaceuticals, Inc.: Market Capitalization to Book Value Ratio

This chart of exchange quotes on the GURU.Markets platform demonstrates the price action of Inovio Pharmaceuticals (INO), whose metric stands at 17.76. Inovio Pharmaceuticals (INO) is advancing the field of genetic medicine by implementing direct delivery of biomaterials for the therapy of cancer and viruses. The business relies on a closed model utilizing unique CELLECTRA injectors, while the team led by Jacqueline Shea is finalizing preparations for the first commercial sales.

Inovio Pharmaceuticals (INO) - Market Capitalization to Book Value Ratio from 07/04/2022 to 10/28/2026

INO (Inovio Pharmaceuticals, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:

Price Chart Inovio Pharmaceuticals|INO - Forecast Levels Chart

- market capitalization data:

Market Capitalization Inovio Pharmaceuticals Inc|INO - Value Adjusted for Debt and Cash

- book capitalization data:

Book Value per Share Inovio|INO - Book Capitalization|Market Value to Book Value Ratio inovio.com|INO - Aggregate Asset Value

- debt and liquidity data:

Debt to Equity Inovio Pharmaceuticals|INO - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Inovio Pharmaceuticals Inc|INO - Company Aggregate Debts|Debt to Book Value Inovio Pharmaceuticals Inc

Basic company analysis:INO (Inovio Pharmaceuticals)

Finished products of Inovio Pharmaceuticals, Inc.

Investors are assessing the resilience of Inovio Pharmaceuticals (INO) through the price-to-book ratio, which determines the market premium over real capital. When analyzing changes in the revaluation of balance sheet capital, it is critical to consider that geopolitical risks and biomaterial supply chain disruptions could compress this premium, turning a local decline into a signal of either fundamental undervaluation or a systemic crisis.

Main competitors